(S (NP (NNP Thyroid) (NN cancer)) (VP (VBZ is) (NP (DT the) (JJS commonest) (JJ endocrine) (NN malignancy))) (. .))
(S (NP (NP (NN Mutation)) (PP (IN in) (NP (DT the) (NNP BRAF) (NN serine/threonine) (NN kinase)))) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ frequent)) (JJ genetic) (NN alteration)) (PP (IN in) (NP (JJ thyroid) (NN cancer))))) (. .))
(S (NP (NP (NN Target) (NN therapy)) (PP (IN for) (NP (ADJP (ADJP (JJ advanced)) (CC and) (ADJP (RB poorly) (VBN differentiated))) (JJ thyroid) (NN carcinomas)))) (VP (VBP include) (NP (NNP BRAF) (NN pathway) (NNS inhibitors))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP MAP3K8) (NN expression))) (PP (IN as) (NP (NP (DT a) (JJ potential) (NN driver)) (PP (PP (IN of) (NP (NP (NN resistance)) (PP (TO to) (NP (NNP BRAF) (NN inhibition))))) (PP (IN in) (NP (JJ thyroid) (NN cancer)))))))) (. .))
(S (PP (IN By) (S (VP (VBG analyzing) (NP (NNP Gene) (NNP Expression) (NNP Omnibus) (NNP data) (NN repository)) (, ,) (PP (IN across) (NP (DT all) (JJ thyroid) (NN cancer) (NNS histotypes))) (, ,)))) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (S (NP (NNP MAP3K8)) (VP (VBZ is) (VP (JJ up-regulated) (PP (IN in) (NP (ADJP (RB poorly) (VBN differentiated)) (JJ thyroid) (NN carcinomas)))))) (CC and) (S (NP (PRP$ its) (NN expression)) (VP (VBZ is) (VP (VBN related) (PP (TO to) (NP (NP (DT a) (ADJP (NN stem) (NN cell) (IN like)) (NN phenotype)) (CC and) (NP (DT a) (JJR poorer) (NN prognosis) (CC and) (NN survival)))))))))) (. .))
(S (S (VP (VBN Taken) (ADVP (RB together)))) (NP (DT these) (NNS data)) (VP (VP (VBP unravel) (NP (NP (DT a) (NN novel) (NN mechanism)) (PP (IN for) (NP (JJ thyroid) (NN cancer) (NN progression) (CC and) (NN chemo-resistance))))) (CC and) (VP (VBP confirm) (NP (NP (JJ previous) (NNS results)) (VP (VBN obtained) (PP (IN in) (NP (JJ cultured) (NN thyroid) (NN cancer) (NN stem) (NNS cells))))))))
